|
1
|
Zhang DQ, Guo Q, Zhu JH and Chen WC:
Increase of cyclooxygenase-2 inhibition with celecoxib combined
with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a
subcutaneous implantation tumor model of human colon cancer. World
J Surg Oncol. 11:162013. View Article : Google Scholar
|
|
2
|
Kalra AV and Campbell RB: Mucin impedes
cytotoxic effect of 5-FU against growth of human pancreatic cancer
cells: overcoming cellular barriers for therapeutic gain. Br J
Cancer. 97:910–918. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
De Graaf TW, Slot SS, Peters GJ and Van
Dijk W: Changes in glycosylation of L1210 cells after exposure to
various antimetabolites. Eur J Cancer. 29A:1760–1765.
1993.PubMed/NCBI
|
|
4
|
Yang JM, Byrd JC, Siddiki BB, et al:
Alterations of O-glycan biosynthesis in human colon cancer tissues.
Glycobiology. 4:873–884. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barrow H, Tam B, Duckworth CA, Rhodes JM
and Yu LG: Suppression of core 1 Gal-transferase is associated with
reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3
glycans in human colon cancer cells. PLoS One. 8:e597922013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Balog CI, Stavenhagen K, Fung WL, et al:
N-glycosylation of colorectal cancer tissues: a liquid
chromatography and mass spectrometry-based investigation. Mol Cell
Proteomics. 11:571–585. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hahne H, Neubert P, Kuhn K, et al:
Carbonyl-reactive tandem mass tags for the proteome-wide
quantification of N-linked glycans. Anal Chem. 84:3716–3724. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Togayachi A, Kozono Y, Ishida H, et al:
Polylactosamine on glycoproteins influences basal levels of
lymphocyte and macrophage activation. Proc Natl Acad Sci USA.
104:15829–15834. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saitoh O, Wang WC, Lotan R and Fukuda M:
Differential glycosylation and cell surface expression of lysosomal
membrane glycoproteins in sublines of a human colon cancer
exhibiting distinct metastatic potentials. J Biol Chem.
267:5700–5711. 1992.
|
|
10
|
Ishida H, Togayachi A, Sakai T, et al: A
novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which
synthesizes poly-N-acetyllactosamine, is dramatically upregulated
in colon cancer. FEBS Lett. 579:71–78. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu S, Chu D, Zhang Y, et al:
EMMPRIN/CD147 expression is associated with disease-free survival
of patients with colorectal cancer. Med Oncol. 30:3692013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang Z, Ge Y, Zhou J, Xu L and Wu SL:
Subcellular localization and tumor distribution of human
beta3-galactosyltransferase by beta3GalT7 antiserum. Hybridoma
(Larchmt). 29:141–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peng ZH, Xing TH, Qiu GQ and Tang HM:
Relationship between Fas/FasL expression and apoptosis of colon
adenocarcinoma cell lines. World J Gastroenterol. 7:88–92.
2001.PubMed/NCBI
|
|
14
|
Tong J, Xie G, He J, Li J, Pan F and Liang
H: Synergistic antitumor effect of dichloroacetate in combination
with 5-fluorouracil in colorectal cancer. J Biomed Biotechnol.
2011:7405642011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Remmers N, Anderson JM, Linde EM, et al:
Aberrant expression of mucin core proteins and o-linked glycans
associated with progression of pancreatic cancer. Clin Cancer Res.
19:1981–1993. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mitsui Y, Yamada K, Hara S, Kinoshita M,
Hayakawa T and Kakehi K: Comparative studies on glycoproteins
expressing polylactosamine-type N-glycans in cancer cells. J Pharm
Biomed Anal. 70:718–726. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Srinivasan N, Bane SM, Ahire SD, Ingle AD
and Kalraiya RD: Poly N-acetyllactosamine substitutions on N- and
not O-oligosaccharides or Thomsen-Friedenreich antigen facilitate
lung specific metastasis of melanoma cells via galectin-3.
Glycoconj J. 26:445–456. 2009. View Article : Google Scholar
|
|
18
|
Nabi IR and Dennis JW: The extent of
polylactosamine glycosylation of MDCK LAMP-2 is determined by its
Golgi residence time. Glycobiology. 8:947–953. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Seko A and Yamashita K: Activation of
beta1,3-N-acetylglucosaminyltransferase-2 (beta3Gn-T2) by
beta3Gn-T8. Possible involvement of beta3Gn-T8 in increasing
poly-N-acetyllactosamine chains in differentiated HL-60 cells. J
Biol Chem. 283:33094–33100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lea MA, Ibeh C, Shah N and Moyer MP:
Induction of differentiation of colon cancer cells by combined
inhibition of kinases and histone deacetylase. Anticancer Res.
27:741–748. 2007.PubMed/NCBI
|
|
21
|
Seko A and Yamashita K: Characterization
of a novel galactose beta1,3-N-acetylglucosaminyltransferase
(beta3Gn-T8): the complex formation of beta3Gn-T2 and beta3Gn-T8
enhances enzymatic activity. Glycobiology. 15:943–951. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Andreuccetti M, Allegrini G, Antonuzzo A,
et al: Azidothymidine in combination with 5-fluorouracil in human
colorectal cell lines: in vitro synergistic cytotoxicity and
DNA-induced strand-breaks. Eur J Cancer. 32A:1219–1226. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Steet RA, Melancon P and Kuchta RD:
3′-Azidothymidine potently inhibits the biosynthesis of highly
branched N-linked oligosaccharides and poly-N-acetyllactosamine
chains in cells. J Biol Chem. 275:26812–26820. 2000.
|
|
24
|
Tang W, Chang SB and Hemler ME: Links
between CD147 function, glycosylation, and caveolin-1. Mol Biol
Cell. 15:4043–4050. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dube DH and Bertozzi CR: Glycans in cancer
and inflammation - potential for therapeutics and diagnostics. Nat
Rev Drug Discov. 4:477–488. 2005. View
Article : Google Scholar : PubMed/NCBI
|
